http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109106713-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd791ac44d80185e2223529cbbc186d1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2017-06-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5adb8b7245e2cdd48373032fb64ff89c |
| publicationDate | 2019-01-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109106713-A |
| titleOfInvention | Indole-3-carbinol, di-indole methyl hydride and its derivative are preparing the application in treating organs graft-rejection drug |
| abstract | The invention proposes indole-3-carbinol, di-indole methyl hydride and its derivatives to prepare the application in treating organs graft-rejection drug, such drug can pass through the expression of the specific gene of the intracellular free radical resisting of raising, enhancing cell actively removes the ability of free radical, mitigates injury of the free radical to cell and tissue.Meanwhile small-molecule drug used in the present invention is easily obtained, cheap, property is stablized, and is convenient for storage and transport, has broad application prospects. |
| priorityDate | 2017-06-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 64 of 64.